Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Malighetti

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Computers in Biology and Medicine|June 2, 2023
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clusteringValentina Crippa, Federica Malighetti, Matteo Villa, et al.
Journal of Translational Medicine|June 19, 2026
Palbociclib targets β-catenin for degradation and synergizes with KRAS or ERK5 inhibition in colorectal cancer preclinical modelsMatteo Villa, Federica Malighetti, Alberto Maria Villa, et al.
Cells|August 7, 2021
FOS Rescues Neuronal Differentiation of Sox2-Deleted Neural Stem Cells by Genome-Wide Regulation of Common SOX2 and AP1(FOS-JUN) Target GenesMiriam Pagin, Mattias Pernebrink, Mattia Pitasi, et al.
NPJ Precision Oncology|August 18, 2025
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancerValentina Crippa, Nicoletta Cordani, Alberto Maria Villa, et al.
Nucleic Acids Research|July 10, 2025
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumorsMatteo Villa, Federica Malighetti, Luca De Sano, et al.
International Journal of Molecular Sciences|March 13, 2025
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering AnalysisFederica Malighetti, Matteo Villa, Alberto Maria Villa, et al.
Nature Communications|September 25, 2023
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patientsDiletta Fontana, Ilaria Crespiatico, Valentina Crippa, et al.
NPJ Precision Oncology|March 6, 2024
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patientsMatteo Villa, Federica Malighetti, Elisa Sala, et al.
International Journal of Molecular Sciences|November 25, 2023
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer CellsNicoletta Cordani, Luca Mologni, Rocco Piazza, et al.
Journal of Cellular and Molecular Medicine|September 1, 2023
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemiaAndrea Aroldi, Mario Mauri, Daniele Ramazzotti, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Computers in Biology and Medicine|June 2, 2023
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clusteringValentina Crippa, Federica Malighetti, Matteo Villa, et al.
Journal of Translational Medicine|June 19, 2026
Palbociclib targets β-catenin for degradation and synergizes with KRAS or ERK5 inhibition in colorectal cancer preclinical modelsMatteo Villa, Federica Malighetti, Alberto Maria Villa, et al.
Cells|August 7, 2021
FOS Rescues Neuronal Differentiation of Sox2-Deleted Neural Stem Cells by Genome-Wide Regulation of Common SOX2 and AP1(FOS-JUN) Target GenesMiriam Pagin, Mattias Pernebrink, Mattia Pitasi, et al.
NPJ Precision Oncology|August 18, 2025
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancerValentina Crippa, Nicoletta Cordani, Alberto Maria Villa, et al.
Nucleic Acids Research|July 10, 2025
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumorsMatteo Villa, Federica Malighetti, Luca De Sano, et al.
International Journal of Molecular Sciences|March 13, 2025
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering AnalysisFederica Malighetti, Matteo Villa, Alberto Maria Villa, et al.
Nature Communications|September 25, 2023
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patientsDiletta Fontana, Ilaria Crespiatico, Valentina Crippa, et al.
NPJ Precision Oncology|March 6, 2024
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patientsMatteo Villa, Federica Malighetti, Elisa Sala, et al.
International Journal of Molecular Sciences|November 25, 2023
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer CellsNicoletta Cordani, Luca Mologni, Rocco Piazza, et al.
Journal of Cellular and Molecular Medicine|September 1, 2023
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemiaAndrea Aroldi, Mario Mauri, Daniele Ramazzotti, et al.
Pageof 2